92 related articles for article (PubMed ID: 6451570)
21. [Studies on the relationship between the activities of aryl hydrocarbon hydroxylase and the intermediate products of benzo(a)pyrene].
Wu YD; Qiu Q; Yu XB; Zhao YJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Feb; 8(1):37-9. PubMed ID: 2943442
[No Abstract] [Full Text] [Related]
22. Developmental differences in basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in chick embryo liver and lung in ovo.
Hamilton JW; Bloom SE
Biochem Pharmacol; 1983 Oct; 32(19):2986-8. PubMed ID: 6626269
[No Abstract] [Full Text] [Related]
23. [Cytochrome P-450 and aryl hydroxylase activity in cells of a long-term transplantable tumor].
Kiseleva MG; Prikhod'ko AZ; Belitskiĭ GA
Biull Eksp Biol Med; 1983 Jul; 96(7):91-3. PubMed ID: 6871462
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.
Held H; Eisert R; von Oldershausen HF
Arzneimittelforschung; 1973 Dec; 23(12):1801-7. PubMed ID: 4801689
[No Abstract] [Full Text] [Related]
25. The biochemical and genetic characteristics of murine ovarian aryl hydrocarbon (benzo[a])pyrene) hydroxylase activity and its relationship to primordial oocyte destruction by polycyclic aromatic hydrocarbons.
Mattison DR; Nightingale MR
Toxicol Appl Pharmacol; 1980 Dec; 56(3):399-408. PubMed ID: 7222024
[No Abstract] [Full Text] [Related]
26. [Effect of trace elements on the hydroxylation of benzo(a)pyrene].
Calop J; Burckhart MF; Fontanges R
Eur J Toxicol Environ Hyg; 1976; 9(5):271-86. PubMed ID: 1009996
[TBL] [Abstract][Full Text] [Related]
27. Specific reduction of hepatic microsomal benzo[a]pyrene hydroxylase activity after administration of eugenol to the rat.
Ohgiya N; Yokota H; Yuasa A
Nihon Juigaku Zasshi; 1988 Aug; 50(4):843-50. PubMed ID: 3172594
[No Abstract] [Full Text] [Related]
28. Aryl hydrocarbon (benzo[a]pyrene) hydroxylase in rat mammary tissue during pregnancy and lactation.
Fysh JM; Okey AB
Can J Physiol Pharmacol; 1979 Jan; 57(1):112-7. PubMed ID: 427641
[No Abstract] [Full Text] [Related]
29. Benzo(a)pyrene hydroxylase activity in enriched populations of Clara cells and alveolar type II cells from control and beta-naphthoflavone-pretreated rats.
Jones KG; Holland JF; Fouts JR
Cancer Res; 1982 Nov; 42(11):4658-63. PubMed ID: 7127302
[TBL] [Abstract][Full Text] [Related]
30. Enzymic control of irreversible binding of metabolically activated benzo(a)pyrene in perfused rat liver by monooxygenase activity.
Kahl GF; Klaus E; Jonen HG; Kahl R
Arch Toxicol; 1977 Dec; 39(1-2):149-58. PubMed ID: 579978
[No Abstract] [Full Text] [Related]
31. High-pressure liquid chromatographic analysis of benzo(a)pyrene metabolism by human lymphocytes from donors of different aryl hydrocarbon hydroxylase inducibility and antipyrine half-lives.
Gurtoo HL; Vaught JB; Marinello AJ; Paigen B; Gessner T; Bolanowska W
Cancer Res; 1980 Apr; 40(4):1305-10. PubMed ID: 7357559
[TBL] [Abstract][Full Text] [Related]
32. High benzo[a]pyrene hydroxylase activity in the marine fish Stenotomus versicolor.
Stegeman JJ; Binder RL
Biochem Pharmacol; 1979 May; 28(10):1686-8. PubMed ID: 475828
[No Abstract] [Full Text] [Related]
33. Aryl hydrocarbon (benzo[a]pyrene) mono-oxygenase activity in human primary amnion cell cultures.
Goto T; Wiebel FJ
Eur J Cancer (1965); 1980 Jun; 16(6):751-61. PubMed ID: 7408926
[No Abstract] [Full Text] [Related]
34. Effects of chronic mestranol and (or)norethindrone treatment on ethanol-associated decreases in hepatic benzo[a]pyrene hydroxylase activity and increases in central vein fat accumulation in the female Wistar rat.
Warren BL; Bellward GD
Can J Physiol Pharmacol; 1983 Aug; 61(8):808-15. PubMed ID: 6627123
[TBL] [Abstract][Full Text] [Related]
35. Effects of polyhalogenated aromatic hydrocarbons on benzo(a)pyrene hydroxylase activity in the intestine and liver.
Manis J; Kim G
Life Sci; 1980 Apr; 26(17):1431-9. PubMed ID: 7382725
[No Abstract] [Full Text] [Related]
36. Polybrominated biphenyl: acute and chronic effect on iron absorption and benzo(a)pyrene hydroxylase.
Manis J; Kim G
Toxicol Appl Pharmacol; 1980 Jun; 54(1):41-7. PubMed ID: 6249001
[No Abstract] [Full Text] [Related]
37. Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.
Buening MK; Chang RL; Huang MT; Fortner JG; Wood AW; Conney AH
Cancer Res; 1981 Jan; 41(1):67-72. PubMed ID: 7448777
[TBL] [Abstract][Full Text] [Related]
38. Sulfadimidine kinetics in patients with various chronic liver diseases.
Horváth T; Past T; Par A; Kádas I; Jávor T
Pol J Pharmacol Pharm; 1988; 40(3):257-64. PubMed ID: 3241767
[TBL] [Abstract][Full Text] [Related]
39. Oocyte destruction by polycyclic aromatic hydrocarbons is not linked to the inducibility of ovarian aryl hydrocarbon (benzo(a)pyrene) hydroxylase activity in (DBA/2N X C57BL/6N) F1 X DBA/2N backcross mice.
Mattison DR; Nightingale MS
Pediatr Pharmacol (New York); 1982; 2(1):11-21. PubMed ID: 7110752
[TBL] [Abstract][Full Text] [Related]
40. Studies on the metabolism and excretion of benzo(a)pyrene in isolated adult rat hepatocytes.
Jones CA; Moore BP; Cohen GM; Fry JR; Bridges JW
Biochem Pharmacol; 1978 Mar; 27(5):693-702. PubMed ID: 656109
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
